Body Biotics, Prescript-Assist, Pet Flora, Children's Body Biotics Probiotics

Sacred Mountain Nutritional SupplementsSacred Mountain, Inc.
Nutritional Supplements


Free Shipping in the United States on orders over $200.00

CCNow our online retailer takes your credit cards
View Shopping Cart

Home > Research > Beneficial Bacteria > Article 3


Research
Beneficial Bacteria
Part 3

Article 3
Got 30 seconds more? Probiotics Basics

Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study

Abstract

Hepato-Gastroenterology Unit, Medical Science Department S. Giuseppe Hospital, Traditional Medicine-WHO Center, University of Milan, Milan, Italy.

BACKGROUND/AIMS: A number of studies have suggested a key role played by certain resident gut bacteria in the development of large bowel cancer. The aim of the present study was to test the effect of a novel symbiotic preparation, which has been recently shown to beneficially modify gut ecosystem and systemic immunity, on either preneoplastic and neoplastic changes in a colon carcinogenesis model. METHODOLOGY: Sprague-Dawley rats were fed a standard diet for 1 week and then were randomly assigned to three groups. The control diet was given to groups A and B, whereas in group C, the same diet plus 2 mL of a probiotic mixture was given throughout the experiment. Thirty rats (groups B, C) each received a weekly subcutaneous injection of azoxymethane at a dose of 15 mg/kg of body weight for 10 weeks. Group A served as a control group and received a subcutaneous injection of saline for 10 weeks. Forty-five rats were sacrificed at 3-week observation and 60 rats at 20-week observation for assessing metaphase index together with aberrant crypt foci and intestinal immune system markers from one hand and tumor occurrence from the other, respectively. RESULTS: Group A showed a significantly increased metaphase index either in aberrant crypt foci or in "normal appearing" crypts when compared to group A (p < 0.01). Group B rats caused a significant decrease at both sites (p < 0.05). The numbers of lymphocytes derived from the mesenteric lymph nodes in group B rats were significantly decreased (p < 0.01) as compared to either control and to group C. The percentage of CD8 lymphocytes in group C was significantly higher than that in group B. Group C showed a significantly reduced ratio of aberrant crypt foci/colon and of aberrant crypt per colon and per each single focus (p < 0.05). A total of 18 (90%) group B and 10 (50%) group C rats had colon tumors, this difference was significant. The mean number of colon tumors per rat was 2.2 and 1.0 in group B and C, respectively. CONCLUSIONS: Effective probiotics treatment, through mechanisms still to be fully elucidated (decreased fecal pH, specific reduction of carcinogenetic bacterial enzymes, modulation of gut-associated and systemic immune system etc.) has the potential to exert significant antimutagenic properties against colon cancer.

Reference:

Hepatogastroenterology. 2003 Nov-Dec;50(54):1914-8

Next - Back to Table of Contents for Beneficial Bacteria, Part 3

Information, statements and products on this website have not been evaluated by the FDA and are not intended to diagnose, mitigate, treat, cure, or prevent any disease or health condition.

View Shopping Cart

Sacred Mountain, Inc. logo

Copyright 1997-2011 Sacred Mountain, Inc.
Privacy Policy | Terms of Use | Map
Body Biotics™ | Prescript-Assist™
| Pet Flora